Axatilimab + CAR-T for High-Risk Lymphoma

NCT07638982 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B Cell Lymphoma (DLBCL)
Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma
High-grade B-cell Lymphoma (HGBCL)
High-Grade B-Cell Lymphoma, Nos
PMBCL
Follicular Grade 3 Lymphoma

Interventions

DRUG: Axatilimab

Sponsor

Northside Hospital, Inc.